Treatment of severe childhood nephrosis.
D000208:Acute Disease; D000477:Alkylating Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003524:Cyclosporins / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007978:Levamisole / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009401:Nephrosis / Q000188:drug therapy*; D012074:Remission Induction
D000477:Alkylating Agents; D003524:Cyclosporins; D005938:Glucocorticoids; D007978:Levamisole